Coloplast A/S (OTCMKTS:CLPBY) Short Interest Up 26.9% in February

Coloplast A/S (OTCMKTS:CLPBY) was the target of a large increase in short interest in February. As of February 28th, there was short interest totalling 77,000 shares, an increase of 26.9% from the February 13th total of 60,700 shares. Based on an average daily trading volume, of 268,300 shares, the days-to-cover ratio is currently 0.3 days.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the stock. Royal Bank of Canada raised shares of Coloplast A/S from a “hold” rating to a “moderate buy” rating in a report on Monday, March 3rd. Sanford C. Bernstein raised shares of Coloplast A/S from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 28th. UBS Group raised shares of Coloplast A/S from a “strong sell” rating to a “hold” rating in a report on Wednesday, December 11th. Finally, Hsbc Global Res raised shares of Coloplast A/S from a “moderate sell” rating to a “hold” rating in a report on Monday, November 18th.

Coloplast A/S Stock Up 0.7 %

CLPBY stock opened at $10.54 on Monday. The firm has a fifty day moving average price of $11.07 and a 200 day moving average price of $12.10. Coloplast A/S has a fifty-two week low of $10.43 and a fifty-two week high of $14.14. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.02 and a quick ratio of 0.66.

Coloplast A/S (OTCMKTS:CLPBY) last issued its quarterly earnings results on Tuesday, February 4th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.01). Coloplast A/S had a return on equity of 28.60% and a net margin of 17.81%. Sell-side analysts forecast that Coloplast A/S will post 0.31 earnings per share for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.